Reports
Reports
The global pulmonary artery catheter market is expected to grow at a CAGR of 4.1% in the forecast period of 2023-2028.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Due to sedentary lifestyles and the increase in cardiac complications, the United States and Canada are the major markets for pulmonary artery catheter within North America. Countries like India, Australia, and New Zealand are also among the major markets of pulmonary artery catheter due to the prevalence of poor diet, failure to exercise, and sedentary lifestyles. Lifestyle disorders are prevalent in these countries, which is further boosting the market growth. Europe and Latin America are also witnessing a rapid growth within the market due to changing lifestyles and increasing investments into the healthcare sectors.
The pulmonary artery takes blood to the lungs for purification from the heart's right ventricle. Catheterisation of the pulmonary artery is a process in which a catheter is inserted into the pulmonary artery. The flow-focused balloon pulmonary artery catheter was first addressed in 1970 and initially designed for the treatment of acute myocardial infarction. It has since then been widely used in various critical diseases and operations. Pulmonary artery catheterisation is a surgical operation that inserts a small catheter into the neck, arm, chest, or vein and transfers to the right side of the heart to assess the heart pressure.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The types of the product can be divided as follows:
Pulmonary artery catheter finds wide applications in:
The end uses of the product include the following:
The regional markets for pulmonary artery catheter can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The rapid rise in the ageing population is among the crucial factors driving the growth of the industry. The demand for pulmonary artery catheters is motivated by the preoperative, perioperative, and postoperative use of the pulmonary artery catheter. The number of cases of cardiac complications has risen with the growing health problems due to the sedentary lifestyles and unhealthy dietary habits. This has led to the growth of the pulmonary artery catheter industry. In addition, the increased prevalence of smoking and alcohol consumption have also resulted in increased heart problems, thus, further catalysing the market growth.
The report gives a detailed analysis of the following key players in the global pulmonary artery catheter market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Application |
|
Breakup by Model of Delivery |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Pulmonary Artery Catheter Market Overview
3.1 Pulmonary Artery Catheter Market Historical Value (2016-2022)
3.2 Pulmonary Artery Catheter Market Forecast Value (2023-2031)
4 Pulmonary Artery Catheter Market Landscape
4.1 Catheter: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Catheter: Product Landscape
4.2.1 Analysis by Device Type
4.2.2 Analysis by Technology
4.2.3 Analysis by End User
5 Pulmonary Artery Catheter Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Pulmonary Artery Catheter Market Segmentation
6.1 Pulmonary Artery Catheter Market by Product
6.1.1 Market Overview
6.1.2 Four Lumen Artery Catheter
6.1.3 Five Lumen Artery Catheter
6.1.4 Six Lumen Artery Catheter
6.1.5 Others
6.2 Pulmonary Artery Catheter Market by Application
6.2.1 Market Overview
6.2.2 ICUs
6.2.3 Non-ICUs
6.2.4 Others
6.3 Pulmonary Artery Catheter Market by Model of Delivery
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Long Term Care Facilities
6.3.4 Other End Users
6.4 Pulmonary Artery Catheter Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Pulmonary Artery Catheter Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Pulmonary Artery Catheter Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Pulmonary Artery Catheter Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Pulmonary Artery Catheter Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Pulmonary Artery Catheter Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Hollister
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Medtronic Plc
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Coloplast
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Becton, Dickinson and Company
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 B. Braun Melsungen AG
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Abbott Laboratories
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Boston Scientific Corporation
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Teleflex Incorporated
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Johnson & Johnson
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Edwards Lifesciences Corporation
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
18.11 Cook Medical
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Mergers and Acquisitions
18.11.5 Certifications
18.12 Stryker Corporation
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Mergers and Acquisitions
18.12.5 Certifications
19 Catheter - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The global pulmonary artery catheter market is projected to grow at a CAGR of 4.1% between 2021 and 2026.
The growth of the market is being supported by drivers like rising population, increasing number of smokers, rising prevalence of diseases caused due to sedentary lifestyles of the consumers, and growing ageing population.
Unhealthy dietary habits and increasing investments into the healthcare sector are the important industry trends propelling the market growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading types of pulmonary artery catheter in the market are four-lumen catheter, five-lumen catheter, and six-lumen catheter, among others.
The major application segments in the industry are ICU and non-ICU.
The significant end use sectors in the market are hospitals, cardiac clinics, and ambulatory surgical centres, among others.
The major players in the industry are Edward Lifesciences Corporation, Argon Medical Devices Inc., ICU Medical Inc., and Biosensors International Group, among others.
The global pulmonary artery catheter market is being driven by the growing prevalence of lifestyle-related diseases. Aided by the rising healthcare sector, the market is expected to witness a moderate growth in the forecast period of 2023-2028, growing at a CAGR of 4.1%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on types, the market is segmented into four-lumen catheter, five-lumen catheter, and six-lumen catheter, among others. On the basis of application, the industry is bifurcated into ICU and non-ICU. By end use, the market is divided into hospitals, cardiac clinics, and ambulatory surgical centres, among others. The major regional markets for pulmonary artery catheter are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Edward Lifesciences Corporation, Argon Medical Devices Inc., ICU Medical Inc., and Biosensors International Group, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.